Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells

Previous studies reported on the safety and applicability of mesenchymal stem/stromal cells (MSCs) to ameliorate pulmonary inflammation in acute respiratory distress syndrome (ARDS). Thus, multiple clinical trials assessing the potential of MSCs for COVID-19 treatment are underway. Yet, as SARS-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Richard, Spohn, Gabriele, Bechtel, Marco, Bojkova, Denisa, Baer, Patrick C., Kuçi, Selim, Seifried, Erhard, Ciesek, Sandra, Cinatl, Jindrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486048/
https://www.ncbi.nlm.nih.gov/pubmed/32950067
http://dx.doi.org/10.1016/j.stemcr.2020.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486048/
https://www.ncbi.nlm.nih.gov/pubmed/32950067
http://dx.doi.org/10.1016/j.stemcr.2020.09.003

Ejemplares similares